See also this year's filing and all EDGAR filings for this company.
PDF Report 0001389545_2018_NovaBay_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001389545, NovaBay Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,995,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 471,000 |
| 3 | remainder_Assets | 613,000 |
| 4 | LiabilitiesCurrent | 4,979,000 |
| 5 | LiabilitiesNoncurrent | 215,000 |
| 6 | remainder_Liabilities | 2,291,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,636,000 |
| 9 | ResearchAndDevelopmentExpense | 410,000 |
| 10 | remainder_Expenses | 16,599,000 |
| 11 | remainder_Revenues | 18,230,000 |
| 12 | remainder_NetIncome | 12,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 10,079,000 |
| 1 | Liabilities | 7,485,000 |
| 2 | Expenses | 25,645,000 |
| 3 | Revenues | 18,230,000 |
| 4 | StockholdersEquity | 2,594,000 |
| 5 | NetIncome | -7,403,000 |
| 6 | ComprehensiveNetIncome | -7,403,000 |
| 7 | BaseVar | 30,725,500 |
| 8 | EconomicCapitalRatio | -0.335 |
Edgar->Model Mapping
Feature Distribution
Change over Time
